Our Pricing

Wegovy Weight Loss: All Doses In Stock UK

Published on: June 03, 2026

Finding wegovy weight loss in stock uk with full dose availability can be challenging during ongoing supply pressures. At Cured Pharmacy, we maintain stock across all Wegovy dose strengths, from the 0.25mg starter pen through to the 2.4mg maintenance dose, with transparent pricing from £79.00 and same-day prescription processing by our UK clinical team.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics the natural GLP-1 hormone your gut releases after eating, which signals satiety to your brain and slows gastric emptying.

In the landmark STEP 1 clinical trial involving 1,961 participants, those receiving once-weekly semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. Approximately 86% of participants on Wegovy achieved at least 5% weight loss, whilst 50% lost 15% or more of their baseline body weight [2].

The medication works through three primary mechanisms: reducing appetite and food cravings, increasing feelings of fullness after smaller portions, and slowing the rate at which your stomach empties food into the small intestine. These combined effects make it significantly easier to maintain a reduced-calorie diet without the intense hunger that typically undermines weight loss efforts.

Wegovy Dosing Schedule: Why All Doses Matter

The Five-Month Titration Protocol

Wegovy requires a gradual dose escalation over 16 to 20 weeks to minimise gastrointestinal side effects whilst your body adapts to the medication. The NHS-recommended titration schedule begins with 0.25mg weekly for four weeks, then 0.5mg for four weeks, followed by 1.0mg, 1.7mg, and finally the maintenance dose of 2.4mg weekly [3].

This stepped approach is clinically essential — patients who escalate too quickly experience significantly higher rates of nausea, vomiting, and treatment discontinuation. Having all doses in stock means you can progress through the titration schedule without treatment interruptions, which is critical for achieving optimal weight loss outcomes and maintaining metabolic adaptation.

Why Wegovy Stock Availability Matters in the UK

The UK has experienced intermittent Wegovy supply constraints since its launch, with many pharmacies unable to guarantee stock across all five dose strengths. Treatment interruptions during the titration phase can compromise your weight loss progress and may require restarting at a lower dose, effectively delaying your journey to the therapeutic 2.4mg maintenance level.

At Cured Pharmacy, we maintain dedicated stock allocation for all Wegovy doses to ensure treatment continuity for our patients. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) works directly with licensed UK wholesalers to secure consistent supply, meaning you can progress through your prescribed dose escalation without the frustration of switching pharmacies or experiencing treatment gaps.

Continuous treatment is particularly important because weight loss with GLP-1 medications is dose-dependent — the STEP trials demonstrated that higher doses produce greater weight reduction [2]. Missing doses or remaining on sub-therapeutic strengths for extended periods reduces the clinical benefit you'll achieve from the medication.

Wegovy Weight Loss in Stock UK: What to Expect

Realistic Weight Loss Timelines

Most patients begin noticing appetite reduction within the first two weeks of starting Wegovy, even at the lowest 0.25mg dose. However, significant weight loss typically becomes apparent after reaching the 1.0mg dose or higher, usually around month three of treatment. The STEP trials showed that weight loss continues progressively throughout the first year, with the majority occurring between months 3 and 9 [2].

Clinical trial data indicates that patients who remain on Wegovy 2.4mg maintain their weight loss for as long as treatment continues, with minimal weight regain compared to those who discontinue the medication [4]. This suggests Wegovy functions as a long-term weight management tool rather than a short-term intervention, requiring ongoing treatment to sustain results.

Managing Wegovy Side Effects

The most common side effects with Wegovy are gastrointestinal: nausea (44% of participants), diarrhoea (30%), vomiting (24%), and constipation (24%) in the STEP 1 trial [2]. These effects are typically mild to moderate, occur most frequently during dose escalation, and diminish over time as your body adapts to the medication.

To minimise gastrointestinal symptoms, eat smaller, more frequent meals rather than large portions, avoid high-fat and heavily spiced foods, and stay well-hydrated throughout the day. Many patients find that taking their weekly injection on the same day each week, preferably in the evening, helps reduce nausea by allowing them to sleep through the initial hours after administration.

Serious side effects are rare but include potential pancreatitis (discontinue immediately if you experience severe abdominal pain), gallbladder problems, and hypoglycaemia if used alongside other diabetes medications. Your UK prescriber will review your full medical history during consultation to ensure Wegovy is appropriate for you, and our clinical team remains available throughout your treatment for any concerns.

How to Order Wegovy from Cured Pharmacy

Three-Minute Online Assessment

Start by completing our free online clinical assessment, which takes under three minutes and asks about your weight history, current medications, and relevant medical conditions. Our UK-registered prescribers review every assessment individually — this isn't an automated process. If Wegovy is clinically appropriate and you meet the MHRA licensing criteria, your prescription will be issued the same day in most cases.

Once approved, your Wegovy prescription is sent directly to our dispensing pharmacy team. We package all medications in 100% discreet, unmarked packaging with no external branding or product descriptions. Most orders are dispatched within 24 hours via tracked courier, with delivery typically within 2-3 working days across the UK. You'll receive tracking information by email as soon as your order ships.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg solution for injection in pre-filled pen – Summary of Product Characteristics. GOV.UK. [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE. [accessed 13 August 2026]
4. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., Rudofsky, G., Tadayon, S., Wadden, T. A., Dicker, D., & STEP 4 Investigators. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment and lifestyle modifications.